![Christopher Anzalone](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Anzalone
Vorstandsvorsitzender bei ARROWHEAD PHARMACEUTICALS, INC.
Vermögen: 85 Mio $ am 31.05.2024
Aktive Positionen von Christopher Anzalone
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.12.2007 | - |
Vorstandsvorsitzender | 01.12.2007 | - | |
Präsident | 01.12.2007 | - | |
Unidym, Inc.
![]() Unidym, Inc. Electronic Production EquipmentElectronic Technology Unidym, Inc. manufactures, develops, and applies carbon nanotubes. It also provides bulk materials to customers and business partners. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Direktor/Vorstandsmitglied | 15.02.2010 | - |
Ablaris Therapeutics, Inc. | Direktor/Vorstandsmitglied | - | - |
Tego Biosciences Corp. | Direktor/Vorstandsmitglied | - | - |
Arrowhead Madison, Inc. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Christopher Anzalone
Ehemalige bekannte Positionen von Christopher Anzalone
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NanoInk, Inc.
![]() NanoInk, Inc. Industrial MachineryProducer Manufacturing NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. | Präsident | - | 01.01.2004 |
Galway Partners LLC | Corporate Officer/Principal | 01.01.1999 | 01.01.2003 |
KRONOS BIO, INC. | Direktor/Vorstandsmitglied | - | - |
VIR BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 03.04.2023 | - |
░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - | |
░░░░░░░░ | - | - | |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - | |
░░░░░░░ | - | - | |
░░░░░░░░░ | - | - | |
░░░░░ ░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Christopher Anzalone
University of California, Los Angeles | Doctorate Degree |
Lawrence University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 16 |
Operativ
Director/Board Member | 10 |
Chief Executive Officer | 4 |
President | 3 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
VIR BIOTECHNOLOGY, INC. | Health Technology |
KRONOS BIO, INC. | Health Technology |
Private Unternehmen | 10 |
---|---|
NanoInk, Inc.
![]() NanoInk, Inc. Industrial MachineryProducer Manufacturing NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. | Producer Manufacturing |
Calando Pharmaceuticals, Inc.
![]() Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | Health Technology |
Nanotope, Inc.
![]() Nanotope, Inc. Pharmaceuticals: MajorHealth Technology Nanotope, Inc. developed pharmaceutical products. The firm's products were used to regenerate specific tissues including neuronal, vascular, bone, myocardial, and cartilage. Its products targeted regeneration for prevention of paralysis associated with spinal cord injury and angiogenesis for advanced wound healing and the treatment of peripheral artery disease. The company was founded by Samuel I. Stupp and Christopher R. Anzalone and was headquartered in Skokie, IL. | Health Technology |
Roche Madison, Inc.
![]() Roche Madison, Inc. Pharmaceuticals: MajorHealth Technology Roche Madison, Inc. provides gene transfer technologies to the pharmaceutical industry. The company was founded in 1995 by Jon Wolff, James Hagstrom and Vladimir Budker and is headquartered in Madison, WI. | Health Technology |
Unidym, Inc.
![]() Unidym, Inc. Electronic Production EquipmentElectronic Technology Unidym, Inc. manufactures, develops, and applies carbon nanotubes. It also provides bulk materials to customers and business partners. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Electronic Technology |
Benet Group LLC
![]() Benet Group LLC Financial ConglomeratesFinance Part of Arrowhead Pharmaceuticals, Inc., Benet Group LLC is a private equity firm. The company is based in Washington. The American company was founded by Christopher Richard Anzalone. Benet Group was acquired by Arrowhead Pharmaceuticals, Inc. on March 13, 2008. | Finance |
Galway Partners LLC | Finance |
Ablaris Therapeutics, Inc. | |
Tego Biosciences Corp. | |
Arrowhead Madison, Inc. |
- Börse
- Insiders
- Christopher Anzalone
- Erfahrung